The University of Chicago Header Logo

Connection

Richard Schilsky to Von Hippel-Lindau Tumor Suppressor Protein

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Von Hippel-Lindau Tumor Suppressor Protein.
Richard Schilsky
Connection Strength
0.015
Von Hippel-Lindau Tumor Suppressor Protein
  1. Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma. Clin Cancer Res. 2004 Apr 15; 10(8):2584-6.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.